Palantir's first-quarter results were phenomenal. Revenue is accelerating, profit margins are high, and it's onboarding new clients. Although business is booming all around, its greatest opportunities ...

The majority of AI projects fail from a lack of foundational integrity. Clean data and integrated systems are the ...

Palantir reported accelerating growth and beat Wall Street's expectations in the 2026 first quarter. The company is expecting continued strong growth over the next two years. Palantir stock trades at ...

Over the past decade, while the rest of us have been screaming at televisions about inverted full-backs, high-press triggers, and whether the striker is “finished” at 29, a bloodless coup has been ...

Spread the love“`html Keras has emerged as one of the most popular deep learning libraries in recent years, notable for its simplicity and ease of use. Whether you’re a seasoned data scientist or a ...

The company maintains an incredible rate of growth. In the first quarter of fiscal 2027, CrowdStrike reported annual ...

SMCI is down 26.6% over the past year, but up 21.43% in the last month and 12.85% year to date. The stock sits 41% below its 52-week high of $62.36 and well off the $19.48 floor printed earlier this ...

Before going further, our price target of $88.66 sits below where Intel trades today, and INTC is one of the most divisive names in semiconductors. Real upside could come from Intel 18A winning a ...

Platforms like Kalshi let millions wager on sports and pop culture. They’re now hoping institutions will use them for big-ticket trading like hedging. By Michael J. de la Merced Most people use ...

GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. Nintendo’s share price dropped almost 8% on Monday as investors ...

Ainos, Inc. (NASDAQ:AIMD) announced on April 17 that it continues to expand deployments of its Smell AI platform, powered by AI Nose technology, across semiconductor, robotics, and healthcare ...